FISCHER JOST 4
4 · AEON Biopharma, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
FISCHER JOST
Director
Transactions
- Award
Class A Common Stock
2024-08-31+36,021→ 96,785 total - Award
Stock Option
2024-08-31+96,210→ 96,210 totalExercise: $0.83Exp: 2034-08-30→ Class A Common Stock (96,210 underlying)
Footnotes (3)
- [F1]Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
- [F2]Includes multiple awards of restricted stock units ("RSUs") in the amounts of 19,286, 6,289, and 35,189 previously granted on April 26, 2023, which were previously reported on July 24, 2023 as derivative securities in Table II due to a clerical error, and which are now being reported as common stock in Table I. The vesting terms for the RSUs have not changed from what was previously reported on July 24, 2023.
- [F3]Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.